Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$6.47 - $9.57 $3,836 - $5,675
-593 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $2,092 - $3,132
232 Added 64.27%
593 $0
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $1,658 - $2,078
121 Added 50.42%
361 $0
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $3,580 - $5,575
240 New
240 $4,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $399M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.